Baker McKenzie CVBA/SCRL
We only have limited information for this firm. Consider the following firms which have provided more information:
The ‘diplomatic’ and ‘passionate’ team at Baker McKenzie CVBA/SCRL leverages the firm’s international network to assist its broad client base with disputes concerning tenders, corporate financing issues, and competition issues involving pricing. Els Janssens and Roel Meers jointly lead the team. Janssens advises numerous clients in the medical device, pharmaceutical, and health services industries, primarily focusing on assisting industry associations with EU policy. Meers is noted for his transactional experience within the Benelux biotech and healthtech markets, where he often advises clients on corporate finance and capital markets transactions. Elisabeth Dehareng maintains a technology and IP focused practice, with particular emphasis on data protection and privacy in the healthcare sector.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Great knowledge of the specificities of the pharmaceutical industry.’
‘Roel Meers is always available, pragmatic, he is business minded and has a solution oriented approach.’
Abbreviated data is displayed for this firm.
Key clients
- Abbott
- Abbvie
Abbreviated data is displayed for this firm.
Work highlights
- Advised Mithra Pharmaceuticals on its senior secured convertible facilities agreement with funds managed by Highbridge Capital Management, LLC and funds managed by Whitebox Advisors LLC, for a three year term, in an amount of up to €100m.
- Advised Biocartis Group on its comprehensive recapitalisation.
Abbreviated data is displayed for this firm.